Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices.

Diabetes Spectr · 2018 · PMC6243215 · PMID 30510393

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

did not reach statistical significanceP = 0.076so close (0.05 < p ≤ 0.1)

Participants found it easier to push down the injection button for dulaglutide compared to exenatide XR or albiglutide, but these differences did not reach statistical significance (average Likert scores 4.8, 4.57, and 4.33, respectively; P = 0.076).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.